Chiropractors in Gardnerville, NV Accepting Medicare
8 Chiropractors found. Showing 1 - 8
 Dr. Walter James Black, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1524 Us Highway 395 N Ste 8, Gardnerville, NV 89410 Phone: 775-782-8816 Fax: 775-782-8816 |
Dr. Christopher Blaha, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 1328 Us Highway 395 N Ste 305, Gardnerville, NV 89410 Phone: 775-392-4545 Fax: 775-392-4547 |
David J Trujillo, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1532 Us Highway 395 N Ste 3, Gardnerville, NV 89410 Phone: 775-782-2910 |
 Miner Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1540 Hwy 395, Ste 3, Gardnerville, NV 89410 Phone: 775-782-7166 Fax: 775-782-7167 |
 Dr. Laura Joan Werner, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1976 Hackamore Ln, Gardnerville, NV 89410 Phone: 775-265-4657 |
Motion Spine And Sport Chiropractic Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1516 Us Highway 395 N, Ste C, Gardnerville, NV 89410 Phone: 775-392-4545 Fax: 775-392-4547 |
Anne Vondruska, LMT Chiropractor - Occupational Health Medicare: Not Enrolled in Medicare Practice Location: 1516 Us Highway 395 N, Suite#d, Gardnerville, NV 89410 Phone: 775-443-7888 |
Dr. Craig Martin Black, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1255 Hwy 395 N, Suite B, Gardnerville, NV 89410 Phone: 775-783-3494 |
News Archive
FDA issues complete response letter to Bristol-Myers Squibb and AstraZeneca's dapagliflozin
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapagliflozin for the treatment of type 2 diabetes in adults.
Valsartan may reduce cardiac illness and death
Results of a study in this week's issue of THE LANCET provide further evidence that a class of drugs that lower blood pressure are a treatment option for older people at high cardiovascular risk. The study also emphasises the importance of early blood-pressure lowering after the start of treatment to reduce the risk of cardiovascular events such as heart attack and stroke.
Positive safety data from BioSante's ongoing LibiGel Phase III study in women with HSDD
BioSante Pharmaceuticals, today announced positive safety data in its ongoing LibiGel Phase III clinical development program.
Psychiatric risk increased in very preterm infants
Children born very preterm are at increased risk for psychiatric disorders in early childhood, study results suggest.
Smokefree laws reduce adult asthma admissions
Results from a UK study show that legislation banning smoking in the workplace and enclosed public spaces significantly reduces emergency hospital admissions for asthma among adults.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Chiropractors
Speech-Language Pathologists
Optometrists
Podiatrists